Percutaneous coronary intervention–related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction

2009 ◽  
Vol 27 (6) ◽  
pp. 712-719 ◽  
Author(s):  
Giuseppe De Luca ◽  
Ettore Cassetti ◽  
Paolo Marino
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Time Delay ◽  
Coronary Intervention ◽  
Primary Angioplasty ◽  
Risk Profile ◽  
St Segment Elevation ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment ◽  
Percutaneous Coronary

scholarly journals Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Mustafa Yurtdaş ◽  
Yalin Tolga Yaylali ◽  
Nesim Aladağ ◽  
Mahmut Özdemir ◽  
Memiş Hilmi Atay
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Primary Percutaneous Coronary Intervention ◽  
Coronary Intervention ◽  
Primary Angioplasty ◽  
Successful Management ◽  
St Segment Elevation ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment ◽  
Percutaneous Coronary

Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Sign in / Sign up

Export Citation Format

Share Document